arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ACCENDRA HEALTH INC/VA/

ACH
$0.30 ▲ +0.03 (+12.48%) at close
Healthcare ·Wholesale-Medical, Dental & Hospital Equipment & Supplies ·USWholesale-Medical, Dental & Hospital Equipment & Supplies
72 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Neutral
auto_awesome

Analytical Summary

ACCENDRA HEALTH INC/VA/ shows mixed fundamentals. However, watch Profit Margin (%) which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $23.0M
Dividend Yield —
Revenue Growth -10.1% ↗
Op. Margin -5.7% ↘
ROIC 6.5% ↗
FCF / Share None
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$613.23M
↓ -10.1% —
Net Income Profit after all expenses
$-6.47M
↑ +74.1% —
Operating Margin Operating profit as % of sales
-5.7%
↓ -310.1% 31th
FCF / Share Free cash flow per share
$-3.19
↓ -753.5% —
Long-Term Debt Long-term obligations
$1.68B
↑ +82.8% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
19
Returns ↑
100
Financial Health ↓
50

Dividend History

Dividend / share · sourced from SEC filings
$0.01 Latest / share
+0.0% YoY
-48.2% 8-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 19 years · 72 quarters